Darryl Conte

Darryl Conte is an Associate Professor at UMass Chan Medical School, holding positions in both the T.H. Chan School of Medicine and the Morningside Graduate School of Biomedical Sciences. He is a faculty member of the RNA Therapeutics Institute, where he conducts research focused on RNA biology and gene regulation mechanisms.

Education

• BS in Mathematics from Rensselaer Polytechnic Institute, Troy, NY
• PhD in Biomedical Sciences from State University of New York, Albany, NY

Dr. Conte's research primarily focuses on RNA interference pathways, particularly in the model organism Caenorhabditis elegans. His work has significantly advanced our understanding of small RNA pathways, including piRNA and siRNA mechanisms, epigenetic regulation, and genome surveillance systems. His laboratory investigates how these RNA-mediated processes control gene expression, maintain genome integrity, and influence developmental processes. Conte's research has revealed critical insights into how RNA silencing pathways function at the molecular level, with implications for understanding fundamental biological processes and potential therapeutic applications.

Analysis of Dr. Conte's publication record shows a consistent focus on RNA biology, with particular emphasis on Argonaute proteins, piRNA pathways, and epigenetic regulation. His most highly cited works explore how small RNA pathways maintain germline integrity and mediate transgenerational epigenetic inheritance in C. elegans. The research demonstrates sophisticated molecular techniques including advanced sequencing methods and genetic approaches to dissect complex RNA regulatory networks.

Dr. Conte has established himself as a leading researcher in the RNA interference field, with numerous publications in high-impact journals including Cell, Nature, and eLife. His work has been widely cited, with several publications exceeding 100 citations, indicating significant impact in the field of RNA biology and epigenetics.

As a principal investigator, Dr. Conte mentors graduate students and postdoctoral researchers in the Morningside Graduate School of Biomedical Sciences and supervises research projects within the RNA Therapeutics Institute. His laboratory collaborates extensively with other researchers at UMass Chan Medical School, particularly with the laboratory of Dr. Craig Mello, Nobel laureate and pioneer in RNA interference research.